A Study Of Panobinostat In Children With Refractory Hematologic Malignancies

Clinical trial NCT01321346 · COMPLETED

Trial details

NCT number: NCT01321346
Sponsor: Therapeutic Advances in Childhood Leukemia Consortium
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Lymphoblastic Leukemia, Acute, Childhood Myelogenous Leukemia, Acute, Childhood Hodgkin's Disease Non-Hodgkin's Lymphoma

Start date: 2011-03-01
Primary completion: 2015-10-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.